NCT03147469

Brief Summary

The influence of different head and neck positions on the effectiveness of ventilation with the Ambu AuraGain airway remains unevaluated. This study aimed to evaluate the influence of different head and neck positions on ventilation with the AuraGain airway. AuraGain will be placed in all patients, and mechanical ventilation will be performed using a volume-controlled mode with a tidal volume of 10 ml/kg. The expiratory tidal volume, peak inspiratory pressure, oropharyngeal leak pressure, and ventilation score will be assessed first for the neutral head position and then for the extended, flexed, and rotated head positions in a random order. Fiberoptic bronchoscopic view will be also assessed for each head and neck positions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 10, 2017

Completed
7 days until next milestone

Study Start

First participant enrolled

May 17, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 5, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 5, 2017

Completed
Last Updated

December 28, 2017

Status Verified

December 1, 2017

Enrollment Period

2 months

First QC Date

May 8, 2017

Last Update Submit

December 26, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Oropharyngeal leak pressure

    The airway pressure at which a leak sound is detected around the patient's mouth and at which the airway pressure has reached equilibrium, when the pressure-limiting valve of the anesthesia breathing system is closed and the fresh gas flow rate was fixed at 3 L/min.

    30 seconds after positioning of head and neck

Secondary Outcomes (4)

  • Peak inspiratory pressure

    30 seconds after positioning of head and neck

  • Expiratory tidal volume

    30 seconds after positioning of head and neck

  • Ventilation score

    30 seconds after positioning of head and neck

  • Fiberoptic score

    30 seconds after positioning of head and neck

Study Arms (4)

Neutral

NO INTERVENTION

After insertion of Ambu AuraGain™, the variables will be assessed at each positions including neutral, flexion, extension, right rotation under random order.

Flexion

EXPERIMENTAL

After positioning the subjects' neck to flexion, the variables will be assessed.

Procedure: Flexion

Extension

EXPERIMENTAL

After positioning the subjects' neck to extension, the variables will be assessed.

Procedure: Extension

Right rotation

EXPERIMENTAL

After positioning the subjects' head to right rotation, the variables will be assessed.

Procedure: Right rotation

Interventions

FlexionPROCEDURE

After changing the position of head and neck of subjects to flexion, the variables were measured.

Flexion
ExtensionPROCEDURE

After changing the position of head and neck of subjects to extension, the variables were measured.

Extension

After changing the position of head and neck of subjects to right flexion, the variables were measured.

Right rotation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults who were to undergo elective surgery under general anaesthesia using supraglottic airway device

You may not qualify if:

  • Patients who had risk factor for difficult intubation
  • BMI \> 30kg/m2
  • Emergency operation without NPO
  • History of cervical spine surgery or disease
  • History of esophageal operation or gastroesophageal reflux disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 110-744, South Korea

Location

Study Officials

  • Jin-Tae Kim, PhD

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: AuraGain will be placed in all patients, and mechanical ventilation will be performed using a volume-controlled mode with a tidal volume of 10 ml/kg. The expiratory tidal volume, peak inspiratory pressure, oropharyngeal leak pressure, and ventilation score will be assessed first for the neutral head position and then for the extended, flexed, and rotated head positions in a random order. Fiberoptic bronchoscopic view will be also assessed for each head and neck positions.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 8, 2017

First Posted

May 10, 2017

Study Start

May 17, 2017

Primary Completion

July 5, 2017

Study Completion

July 5, 2017

Last Updated

December 28, 2017

Record last verified: 2017-12

Locations